Article
Melanoma plasticity is controlled by a TRIM28-JUNB mediated switch
2019-09-20
Abstract excerpt
The introduction of immune checkpoint blockade has revolutionized the treatment of metastatic melanoma 1 . However, 40-60% of patients with metastatic melanoma do not respond to immune checkpoint blockade, and a significant fraction of patients acquire resistance to treatment 2,3 . This resilience and aggressiveness of melanoma tumors is partly due to their ability to switch between invasive and proliferative st...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8cd51ea7-3896-5b05-bc65-386dc33cbe23
- DOI
- 10.1101/777771
